A practical financial review of extract purchasing, preparation, and injection clinic capacity
An immunotherapy program can remain busy while becoming less profitable. Extract prices rise, preparation consumes staff time, and injection sessions require coverage even when attendance is uneven. When insurance contracts limit reimbursement, a practice may have little ability to recover those increases simply by charging more.
The response starts with visibility. Owners need to understand what it costs to prepare each prescription, what the practice actually collects, and how much safe injection capacity each staffed session provides. This article focuses on conventional subcutaneous allergen immunotherapy, or SCIT, and the financial decisions surrounding its delivery.
Observed purchase prices at one allergy practice across selected 2025 and 2026 invoices. Not an industrywide rate.
English walnut pollen was $140.84 per 10 mL stock vial in November and December 2025 and $176.04 in July 2026, an increase of approximately 25%. The earlier January 2025 price was $128.03, making the increase to August 2026 approximately 37.5%…
Free. The download unlocks right here the moment you subscribe — no waiting on an email. One subscription unlocks every ORYNT brief.
We never ask for patient data. Unsubscribe any time. Privacy
Put the outlook to work on your own numbers.
SEE THE PLANNER